ASTELLAS PHARMA (PTY) LTD
Astellas Pharma (Pty) Ltd is a private company registered in South Africa. Cross-referencing Zavia’s registry-linkage data against independent South African company-information sources indicates a registration number of 2002/024956/07 and an incorporation date of 9 October 2002; the on-file registry fields for this record do not currently show these values. The company’s registered status is recorded as active, and it operates from Bedfordview, Gauteng, in the Johannesburg metropolitan area.
The South African entity’s own history dates to June 2003, when it began trading locally as Yamanouchi Pharma, several years before Yamanouchi Pharmaceutical’s 2005 global merger with Fujisawa Pharmaceutical formed Astellas Pharma Inc.; the local company was subsequently renamed Astellas Pharma (Pty) Ltd to align with the merged group’s global branding.
Astellas Pharma (Pty) Ltd functions as the Astellas group’s operating affiliate for the South African pharmaceutical market, distributing prescription medicines and providing medical information to healthcare professionals. Trade-press coverage of the affiliate has described a historical focus on the therapy areas of transplantation, urology and dermatology, alongside other areas covered by Astellas’s broader global portfolio, including oncology and infectious diseases.
Astellas Pharma (Pty) Ltd is not itself listed on any stock exchange. The website recorded on file for this entry, astellas.eu, is Astellas’s regional site for Europe, the Middle East and Africa rather than a dedicated South African domain; that regional site does include a South Africa contact and locations page, but no separate astellas.co.za country site was identified during this research.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
Shareholders of Astellas Pharma (Pty) Ltd
No shareholder register for Astellas Pharma (Pty) Ltd was located during this research. South African private companies file shareholder and beneficial-ownership information with the Companies and Intellectual Property Commission (CIPC), but CIPC’s ownership records are not freely browsable online and generally require a paid, direct company search to access. Zavia’s own registry-linkage data associates this entry with the wider Astellas Pharma Inc. corporate group (see Group structure), consistent with the company operating as an affiliate of a larger pharmaceutical group, but no named shareholder or ownership percentage specific to Astellas Pharma (Pty) Ltd could be independently confirmed as of September 2026.
Data availability
Shareholder and beneficial-ownership information for this South African entity is classified as Restricted: CIPC holds such records for registered companies, but they are not published for free public inspection, and no confirmatory filing was accessible during this research.
Sources
- Companies and Intellectual Property Commission (CIPC), South Africa — https://www.cipc.co.za — retrieved 2026-09-11
- Zavia.ai internal registry-linkage data for company ID 199519771 — retrieved 2026-09-11
Officers
Directors and officers of Astellas Pharma (Pty) Ltd
No CIPC director filing for Astellas Pharma (Pty) Ltd was accessible during this research; CIPC’s live director register requires a paid company search that could not be completed here. Independent trade-press and business-networking sources have referred to a “Managing Director” for the South African affiliate at different points in time — reported as Derek Haynes in earlier coverage and, in more recent third-party coverage, Barnaby McKay — but neither reference could be verified against a primary CIPC filing or an official Astellas announcement, and neither source discloses an appointment date, nationality or country of residence. These names are therefore reported here only as unverified secondary references rather than confirmed company officers. No nationality has been inferred from any person’s name, and no officially disclosed nationality was found for anyone associated with this company.
Data availability
Officer information for this entity is classified as Not found: no accessible CIPC filing, court record or official Astellas announcement identifying the company’s current directors, secretaries or their appointment dates was located as of September 2026.
Sources
- Companies and Intellectual Property Commission (CIPC), South Africa — https://www.cipc.co.za — retrieved 2026-09-11
- PharmaBoardroom, “Astellas Pharma Ltd. South Africa” — https://pharmaboardroom.com/directory/astellas-pharma-ltd-south-africa/ — retrieved 2026-09-11 (unverified secondary source, references a former Managing Director)
Group Structure
Group structure of Astellas Pharma (Pty) Ltd
Astellas Pharma (Pty) Ltd is part of the Astellas Pharma corporate group. Its ultimate parent is Astellas Pharma Inc., a Japanese company whose shares are listed on the Tokyo Stock Exchange under Securities Code 4503, as confirmed by Astellas Pharma Inc.’s own official shareholder-meeting notices and news releases. Zavia’s registry-linkage data records a matching Japanese corporate number for Astellas Pharma Inc. and positions Astellas Pharma (Pty) Ltd directly beneath it in the group’s corporate tree, alongside dozens of other national Astellas operating companies across Europe, Asia, the Americas and the Middle East. However, no South African CIPC shareholder filing or other primary-source document confirming the immediate parent and ownership percentage for Astellas Pharma (Pty) Ltd was located during this research. The immediate-parent relationship and any intermediate regional holding entity are therefore presented as a possible relationship pending confirmation, while the ultimate-parent identity is well established. No direct or indirect subsidiaries of Astellas Pharma (Pty) Ltd itself were identified.
Verified corporate relationships
| Entity | Country | Registration number | Relationship | Ownership | Status | Information date |
|---|---|---|---|---|---|---|
| Astellas Pharma Inc. | Japan | JP 5010001034966 | Ultimate parent (possible immediate parent, unconfirmed) | Ownership percentage not disclosed | Active; listed, Tokyo Stock Exchange (4503) | 2026-09-11 |
Data availability
Group-structure information for this entity is classified as Partial: the ultimate parent is well established through official Astellas sources, but the immediate-ownership chain, any intermediate regional holding entity, and the ownership percentage were not confirmed via a primary South African filing.
Sources
- Astellas Pharma Inc., Notice of Convocation of Annual Shareholders’ Meeting (Securities Code 4503) — https://www.astellas.com/content/dam/astellas-com/global/en/documents/fy2025-notice-of-convocation-of-the-20th-term-annual-shareholders-meeting-revised.pdf — retrieved 2026-09-11
- Zavia.ai internal registry-linkage data for company ID 199519771 — retrieved 2026-09-11
ASTELLAS PHARMA INC.
Japan
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
What is Astellas Pharma (Pty) Ltd?
Astellas Pharma (Pty) Ltd is the South African operating affiliate of the Japanese pharmaceutical group Astellas Pharma Inc. It distributes prescription medicines and provides medical information to healthcare professionals in South Africa.
What is the registration number of Astellas Pharma (Pty) Ltd?
Cross-referencing multiple South African company-information sources indicates a CIPC registration number of 2002/024956/07. This number is not currently populated in Zavia's on-file registry field for this company.
When was Astellas Pharma (Pty) Ltd incorporated?
Available South African company-information sources indicate an incorporation date of 9 October 2002, though the local business only began trading under the Astellas name after the 2005 merger that created Astellas Pharma Inc.
Where is Astellas Pharma (Pty) Ltd located?
The company operates from Bedfordview, Gauteng, in the Johannesburg metropolitan area, South Africa.
Was Astellas Pharma (Pty) Ltd previously known by another name?
Yes. The South African entity began trading in June 2003 as Yamanouchi Pharma, and was renamed Astellas Pharma (Pty) Ltd following Yamanouchi Pharmaceutical's 2005 global merger with Fujisawa Pharmaceutical to form Astellas Pharma Inc.
Is astellas.eu the official website for Astellas Pharma (Pty) Ltd in South Africa?
The website recorded on file, astellas.eu, is Astellas's shared regional site for Europe, the Middle East and Africa rather than a dedicated South African domain, although it does include a South Africa contact and locations page. No separate astellas.co.za site was identified.
Who owns Astellas Pharma (Pty) Ltd?
No South African shareholder filing for Astellas Pharma (Pty) Ltd could be accessed during this research; CIPC beneficial-ownership records exist but require a paid company search. The company is understood to operate as part of the wider Astellas Pharma group.
Who is the ultimate parent company of Astellas Pharma (Pty) Ltd?
The ultimate parent is Astellas Pharma Inc., a Japanese company listed on the Tokyo Stock Exchange under Securities Code 4503. The exact immediate parent and any intermediate regional holding entity for the South African affiliate were not confirmed via a primary filing.
Is Astellas Pharma (Pty) Ltd listed on a stock exchange?
No. Astellas Pharma (Pty) Ltd is a private South African subsidiary and is not itself listed. Its ultimate parent, Astellas Pharma Inc., is listed on the Tokyo Stock Exchange (4503).
Who are the directors of Astellas Pharma (Pty) Ltd?
No CIPC director filing for the company was accessible during this research. Secondary sources have referred to different individuals holding the title "Managing Director" at different times, but none of this could be verified against an official filing or company announcement.
What therapeutic areas does Astellas Pharma (Pty) Ltd focus on?
Trade-press coverage has described a historical focus on transplantation, urology and dermatology, alongside other therapy areas covered by Astellas Pharma Inc.'s broader global portfolio, such as oncology and infectious diseases.
What is the current registered status of Astellas Pharma (Pty) Ltd?
Zavia's on-file registry data records the company's status as active, sourced from the Companies and Intellectual Property Commission (CIPC) of South Africa.